BRPI0707948A2 - inibição baseado em peptìdeo da interação capcna em cáncer - Google Patents

inibição baseado em peptìdeo da interação capcna em cáncer Download PDF

Info

Publication number
BRPI0707948A2
BRPI0707948A2 BRPI0707948-6A BRPI0707948A BRPI0707948A2 BR PI0707948 A2 BRPI0707948 A2 BR PI0707948A2 BR PI0707948 A BRPI0707948 A BR PI0707948A BR PI0707948 A2 BRPI0707948 A2 BR PI0707948A2
Authority
BR
Brazil
Prior art keywords
capcna
cancer
peptide
cell
pcna
Prior art date
Application number
BRPI0707948-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert J Hickey
Linda H Malkas
Original Assignee
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Indiana Res & Tech Corp filed Critical Univ Indiana Res & Tech Corp
Publication of BRPI0707948A2 publication Critical patent/BRPI0707948A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0707948-6A 2006-02-17 2007-02-16 inibição baseado em peptìdeo da interação capcna em cáncer BRPI0707948A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74331306P 2006-02-17 2006-02-17
US60/743.313 2006-02-17
PCT/US2007/062335 WO2007098415A2 (en) 2006-02-17 2007-02-16 Peptide based inhibition of capcna protein-protein interactions in cancer

Publications (1)

Publication Number Publication Date
BRPI0707948A2 true BRPI0707948A2 (pt) 2011-05-17

Family

ID=38235155

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0707948-6A BRPI0707948A2 (pt) 2006-02-17 2007-02-16 inibição baseado em peptìdeo da interação capcna em cáncer

Country Status (9)

Country Link
US (3) US8653039B2 (cg-RX-API-DMAC7.html)
EP (1) EP1989225A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009527498A (cg-RX-API-DMAC7.html)
CN (1) CN101384618A (cg-RX-API-DMAC7.html)
AU (1) AU2007217037A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0707948A2 (cg-RX-API-DMAC7.html)
CA (1) CA2638866C (cg-RX-API-DMAC7.html)
EA (1) EA200801847A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007098415A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ
WO2008036929A2 (en) * 2006-09-21 2008-03-27 Alnylam Pharmaceuticals, Inc. Complex for transferring an anionic substance into a cell
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CA2732737C (en) * 2008-07-24 2019-03-05 Indiana University Research And Technology Corporation Cancer peptide therapeutics
FR2942798B1 (fr) * 2009-03-05 2011-04-08 Centre Nat Rech Scient Peptides utilisables pour le traitement de la leucemie lymphoide chronique
WO2011044374A1 (en) * 2009-10-07 2011-04-14 Indiana University Research And Technology Corporation Capcna peptide therapeutics for cancer
EP2538959A1 (en) * 2010-02-24 2013-01-02 Institut National de la Santé et de la Recherche Médicale Compounds for the treatment of inflammation and neutropenia
JP2013522613A (ja) * 2010-03-18 2013-06-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 化学療法に対する応答性を予測するための方法
US9475840B2 (en) 2012-02-27 2016-10-25 Universitat De Barcelona Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
GB201214007D0 (en) * 2012-08-07 2012-09-19 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
JP2020514256A (ja) * 2016-12-15 2020-05-21 ザ ナショナル インスティチュート フォー バイオテクノロジー イン ザ ネゲヴ,リミテッド 抗pcnaモノクローナル抗体及びその使用
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935797A (en) 1994-06-16 1999-08-10 Stanford University Interaction of MHC Class II proteins with members of the PCNA family of proteins
GB9509557D0 (en) * 1995-05-11 1995-07-05 Univ Dundee PCNA binding substance
JP2002518341A (ja) * 1998-06-15 2002-06-25 アーチ・デヴェロップメント・コーポレイション 放射線療法と抗血管形成因子の組み合わせ
US7294471B2 (en) 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen
MX2007013584A (es) 2005-04-27 2008-04-22 Univ Indiana Res & Tech Corp Anticuerpos de isoforma de cspcna y sus usos.
DE602006021178D1 (de) 2005-06-27 2011-05-19 Univ Indiana Res & Tech Corp Cspcna-isoform-modifikationen und anwendungen davon
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ

Also Published As

Publication number Publication date
US9187526B2 (en) 2015-11-17
EP1989225A2 (en) 2008-11-12
CN101384618A (zh) 2009-03-11
US20140296156A1 (en) 2014-10-02
US20090232882A1 (en) 2009-09-17
CA2638866A1 (en) 2007-08-30
US20160304559A1 (en) 2016-10-20
WO2007098415A3 (en) 2007-12-13
US8653039B2 (en) 2014-02-18
AU2007217037A1 (en) 2007-08-30
WO2007098415A2 (en) 2007-08-30
CA2638866C (en) 2015-11-10
JP2009527498A (ja) 2009-07-30
EA200801847A1 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
CA2638866C (en) Peptide based inhibition of capcna protein-protein interactions in cancer
US8278278B2 (en) Cell proliferation reducing cancer specific PCNA peptides
CN102015758B (zh) 寡肽化合物及其应用
CA2732737C (en) Cancer peptide therapeutics
US20160264636A1 (en) Peptide inhibitors of tead/yap-taz interaction
JP2009527498A5 (cg-RX-API-DMAC7.html)
US9567369B2 (en) Method of treating metastatic cancer
US20210024595A1 (en) Disruption of the wave3 protein complex for suppression of invasion and metastasis
JP2008508363A (ja) δプロテインキナーゼCの調節のためのペプチド配列
US8404806B2 (en) Isolated BRCA1 peptides and method of use
US20140005119A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS
EP2429563B1 (en) Peptide able to disrupt the protein complex between the his273 mutated p53 protein and the oncosuppressive p73 protein in tumour cells and therapeutic uses thereof
WO2006070804A1 (ja) テロメレース活性阻害方法および阻害剤
BR112021003812A2 (pt) terapias peptídicas para o tratamento de câncer e usos das mesmas
Aubut Interactions Between VASP and Metavinculin
HK1214177B (en) Cancer peptide therapeutics

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired